Abstract

P2X7 receptor activation induces the release of different cellular proteins, such as CD14, a glycosylphosphatidylinositol (GPI)-anchored protein to the plasma membrane important for LPS signaling via TLR4. Circulating CD14 has been found at elevated levels in sepsis, but the exact mechanism of CD14 release in sepsis has not been established. Here we show for first time that P2X7 receptor induces the release of CD14 in extracellular vesicles, resulting in a net reduction in macrophage plasma membrane CD14 that functionally affects LPS, but not monophosphoryl lipid A, pro-inflammatory cytokine production. Also, we found that during a murine model of sepsis, P2X7 receptor activity is important for maintaining elevated levels of CD14 in biological fluids and a decrease in its activity results in higher bacterial load and exacerbated organ damage, ultimately leading to premature deaths. Our data reveal that P2X7 is a key receptor for helping to clear sepsis because it maintains elevated concentrations of circulating CD14 during infection.

Data availability

All data generated or analysed during this study are included in the manuscript and provided as raw data as single values for all Figures.

Article and author information

Author details

  1. Cristina Alarcón-Vila

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
  2. Alberto Baroja-Mazo

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
  3. Carlos de Torre-Minguela

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3314-3203
  4. Carlos M Martínez

    Pathology Platform, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3307-1326
  5. Juan J Martínez-García

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
  6. Helios Martínez-Banaclocha

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
  7. Carlos García-Palenciano

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    Competing interests
    The authors declare that no competing interests exist.
  8. Pablo Pelegrin

    Molecular Inflammation and Experimental Surgery, Biomedical Research Institute of Murcia IMIB-Arrixaca, Murcia, Spain
    For correspondence
    pablo.pelegrin@imib.es
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9688-1804

Funding

European research council (614578)

  • Pablo Pelegrin

European Research council (899636)

  • Carlos García-Palenciano
  • Pablo Pelegrin

Ministerio de Economía y Competitividad (SAF2017-88276-R)

  • Pablo Pelegrin

Fundacion Seneca (20859/PI/18)

  • Carlos García-Palenciano
  • Pablo Pelegrin

Fundacion Seneca (21081/PDC/19)

  • Pablo Pelegrin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experimental protocols for animal handling were refined and approved by the Animal Health Service of the General Directorate of Fishing and Farming of the Council of Murcia (Servicio de Sanidad Animal, Dirección General de Ganadería y Pesca, Consejería de Agricultura y Agua Región de Murcia, permit reference A1320140201). Mice were used in accordance with the Hospital Clínico Universitario Virgen Arrixaca animal experimentation guidelines (Permit Number 221116/1/PE), and Spanish national (Royal Decree 1201/2005 and Law 32/2007) and EU (86/609/EEC and 335 2010/63/EU) legislation. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Human subjects: The samples and data from patients included in this study were provided by the Biobanco en Red de la Región de Murcia (PT13/0010/0018), which is integrated into the Spanish National Biobanks Network (B.000859) and approved by the clinical ethics committee of the Clinical University Hospital Virgen de la Arrixaca (reference numbers PI13/00174, 2019-9-4-HCUVA, 2019-12-15-HCUVA and 2019-12-471 14-HCUVA). All study procedures were conducted in accordance with the declaration of Helsinki. Whole peripheral blood samples were collected after receiving written informed consent from intraabdominal sepsis patients at the Surgical Critical Unit from the Clinical University Hospital Virgen de la Arrixaca.

Copyright

© 2020, Alarcón-Vila et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,368
    views
  • 292
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cristina Alarcón-Vila
  2. Alberto Baroja-Mazo
  3. Carlos de Torre-Minguela
  4. Carlos M Martínez
  5. Juan J Martínez-García
  6. Helios Martínez-Banaclocha
  7. Carlos García-Palenciano
  8. Pablo Pelegrin
(2020)
CD14 release induced by P2X7 receptor restrict inflammation and increases survival during sepsis
eLife 9:e60849.
https://doi.org/10.7554/eLife.60849

Share this article

https://doi.org/10.7554/eLife.60849

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Malika Hale, Kennidy K Takehara ... Marion Pepper
    Research Article

    Pseudomonas aeruginosa (PA) is an opportunistic, frequently multidrug-resistant pathogen that can cause severe infections in hospitalized patients. Antibodies against the PA virulence factor, PcrV, protect from death and disease in a variety of animal models. However, clinical trials of PcrV-binding antibody-based products have thus far failed to demonstrate benefit. Prior candidates were derivations of antibodies identified using protein-immunized animal systems and required extensive engineering to optimize binding and/or reduce immunogenicity. Of note, PA infections are common in people with cystic fibrosis (pwCF), who are generally believed to mount normal adaptive immune responses. Here, we utilized a tetramer reagent to detect and isolate PcrV-specific B cells in pwCF and, via single-cell sorting and paired-chain sequencing, identified the B cell receptor (BCR) variable region sequences that confer PcrV-specificity. We derived multiple high affinity anti-PcrV monoclonal antibodies (mAbs) from PcrV-specific B cells across three donors, including mAbs that exhibit potent anti-PA activity in a murine pneumonia model. This robust strategy for mAb discovery expands what is known about PA-specific B cells in pwCF and yields novel mAbs with potential for future clinical use.

    1. Cell Biology
    2. Immunology and Inflammation
    Alejandro Rosell, Agata Adelajda Krygowska ... Esther Castellano Sanchez
    Research Article

    Macrophages are crucial in the body’s inflammatory response, with tightly regulated functions for optimal immune system performance. Our study reveals that the RAS–p110α signalling pathway, known for its involvement in various biological processes and tumourigenesis, regulates two vital aspects of the inflammatory response in macrophages: the initial monocyte movement and later-stage lysosomal function. Disrupting this pathway, either in a mouse model or through drug intervention, hampers the inflammatory response, leading to delayed resolution and the development of more severe acute inflammatory reactions in live models. This discovery uncovers a previously unknown role of the p110α isoform in immune regulation within macrophages, offering insight into the complex mechanisms governing their function during inflammation and opening new avenues for modulating inflammatory responses.